Skip to content

EU · EudraLex Vol.4

EU GMP Annex 1 9.34

9. Environmental & process monitoring › Aseptic process simulation (APS) (also known as media fill)

Section text

The APS should take into account various aseptic manipulations and interventions known to occur during normal production as well as worst-case situations, and take into account the following:

i. Inherent and corrective interventions representative of the routine process should be performed in a manner and frequency similar to that during the routine aseptic process.

ii. The inclusion and frequency of interventions in the APS should be based on assessed risks posed to product sterility.

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.